1.69
-2.87%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About TherapeuticsMD
From its filings with the US Securities and Exchange Commission
TherapeuticsMD is based in Boca Raton, Florida and is incorporated in Nevada. Its shares trade on Nasdaq under the ticker TXMD. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2024, it reported revenue of $1.8m.
2025 10-K Report, this information could prove to be inaccurate as a result of a variety of matters.
2025 10-K Report do not include any adjustments that might be necessary if we are unable to continue as a going concern.
Regulatory Exclusivity” below for information regarding our intellectual property and challenges to that intellectual property.
Quoted from its 10-K, filed 30 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 31 Jan 2001
- Employees
- 348
- Website
- therapeuticsmd.com ↗
- Head office
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Incorporated in
- NV
- Classification
- Pharmaceutical Preparations
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Gov. Thomas ThompsonIndependent Chairman of the Board, since 2012$101,758
- Mr. Marlan WalkerChief Executive Officer$759,174
- Mr. Joseph ZieglerPrincipal Financial Officer, Principal Accounting Officer$120,000
- Mr. Cooper CollinsIndependent Director$99,500
- Dr. Gail NaughtonIndependent Director$77,500
- Mr. Justin RobertsIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 15
- Environment
- 16
- Social
- 18
- Governance
- 11
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- TherapeuticsMD Inc employs 348 full-time staff members in Boca Raton, Florida.
- The company utilizes its proprietary SYMBODA technology to develop hormone therapy products.
- TherapeuticsMD Inc offers a diverse product line including vitaTrue and vitaMedMD Plus.
Weaknesses
- The company operates exclusively in the United States, limiting its geographic reach.
- TherapeuticsMD Inc focuses primarily on women's health, creating a narrow market segment.
- The firm is still pursuing regulatory approvals for its hormone therapy pharmaceutical products.
Opportunities
- TherapeuticsMD Inc can expand its commercialization of bio-identical hormone delivery systems.
- The company may increase sales of its prenatal multivitamin products like vitaMedMD One Rx Prenatal Multivitamin.
- TherapeuticsMD Inc can leverage its SYMBODA technology to develop new dosage forms for menopause-related symptoms.
Threats
- TherapeuticsMD Inc faces risks from delays in obtaining regulatory approvals for its drug candidates.
- Competitors in the pharmaceutical industry may develop alternative treatments for menopause-related health risks.
- The company's reliance on pre-commercialization activities creates financial uncertainty before product launch.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.